Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)

✍ Scribed by A.Michael Lincoff; Neal S. Kleiman; Kandace Kottke-Marchant; Elizabeth S. Maierson; Kelly Maresh; Katherine E. Wolski; Eric J. Topol

• Book ID: 117842804
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 117 KB
• Volume: 143
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1067/mhj.2002.122173